Pfizer announced on Wednesday that it will offer about 20 products at non-profit prices, including the best-selling COVID-19 vaccines and remedies in the world’s poorest countries.
He announced the program at the World Economic Forum’s annual meeting in Davos, Switzerland, stating that it aims to improve health inequalities in 45 low-income countries. Most countries are in Africa, but the list also includes Haiti, Syria, Cambodia and North Korea.
Widely available in the United States and the European Union, products include 23 medicines and vaccines that treat infections, some cancers, and rare inflammatory conditions. Pam Eisel, a spokeswoman for the company, said there are currently very few medicines and vaccines available in 45 countries.
New York-based Pfizer charges only manufacturing and “minimal” distribution costs, Eisel said. Comply with sanctions and all other applicable laws.
Earlier this month, the head of the World Health Organization called on Pfizer to make COVID-19 treatment more widely available in poorer countries. Pfizer states that the COVID-19 vaccine Comirnaty is already being offered non-profit to poor counties through the US government, which buys and distributes shots for free.
According to data company FactSet, Comirnaty reached sales of about $ 37 billion last year, and analysts expect its COVID-19 treatment Paxlovid to add about $ 24 billion this year.
Pfizer provides low-priced medicines and vaccines to poor countries
Source link Pfizer provides low-priced medicines and vaccines to poor countries